Is There Enough Capital on the Sidelines to Really Support the Sector?

Is there enough capital and interest sitting around the table to actually be able to cover that? Yeah, I think there is. The dedicated investors indicate to us that they're looking to get involved in a more meaningful way. And you know, historically where we've seen the generalists come in is around paradigm shifting results. If we see continued success in gene editing, if some of the commercial launches of the recently approved gene therapies go better than expected,. That's going to draw in generalist investors.